Selected research
Industry Research
Glycosidases Industry Research Report 2026
Market perspective
The global Glycosidases market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Glycosidases is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Glycosidases is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Glycosidases is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Glycosidases include Thermo Fisher Scientific, Waters Corporation, Vaupell Holdings, Takara Bio, Sumitomo Bakelite, Shimadzu Analytical, S-BIO, RayBiotech and RandD Systems, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Glycosidases market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Glycosidases Market by Company
Thermo Fisher Scientific
Waters Corporation
Vaupell Holdings
Takara Bio
Sumitomo Bakelite
Shimadzu Analytical
S-BIO
RayBiotech
RandD Systems
PerkinElmer
New England Biolabs
Merck Group
Geno Technology
FUJIFILM Wako Pure Chemical Corporation
Danaher
Cambridge Isotope Laboratories
Bruker
Agilent Technologies
Glycosidases Segment by Type
Endoglycosidase
Exoglycosidase
Glycosidases Segment by Application
Academic Research Institutes
Pharmaceutical And Biotechnology Companies
Others
Glycosidases Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycosidases market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glycosidases and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycosidases.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Glycosidases manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Glycosidases by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Glycosidases in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Endoglycosidase
- Exoglycosidase
Applications
- Academic Research Institutes
- Pharmaceutical And Biotechnology Companies
- Others
Companies covered
- Thermo Fisher Scientific
- Waters Corporation
- Vaupell Holdings
- Takara Bio
- Sumitomo Bakelite
- Shimadzu Analytical
- S-BIO
- RayBiotech
- RandD Systems
- PerkinElmer
- New England Biolabs
- Merck Group
- Geno Technology
- FUJIFILM Wako Pure Chemical Corporation
- Danaher
- Cambridge Isotope Laboratories
- Bruker
- Agilent Technologies
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Glycosidases Market Size (2021-2032)
- 2.2.2 Global Glycosidases Sales (2021-2032)
- 2.2.3 Global Glycosidases Market Average Price (2021-2032)
- 2.3 Glycosidases by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Endoglycosidase
- 2.3.3 Exoglycosidase
- 2.4 Glycosidases by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Academic Research Institutes
- 2.4.3 Pharmaceutical And Biotechnology Companies
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Glycosidases Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Glycosidases Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Glycosidases Revenue of Manufacturers (2021-2026)
- 3.4 Global Glycosidases Average Price by Manufacturers (2021-2026)
- 3.5 Global Glycosidases Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Glycosidases, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Glycosidases, Product Type & Application
- 3.8 Global Manufacturers of Glycosidases, Established Date
- 3.9 Global Glycosidases Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Thermo Fisher Scientific
- 4.1.1 Thermo Fisher Scientific Company Information
- 4.1.2 Thermo Fisher Scientific Business Overview
- 4.1.3 Thermo Fisher Scientific Glycosidases Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Thermo Fisher Scientific Glycosidases Product Portfolio
- 4.1.5 Thermo Fisher Scientific Recent Developments
- 4.2 Waters Corporation
- 4.2.1 Waters Corporation Company Information
- 4.2.2 Waters Corporation Business Overview
- 4.2.3 Waters Corporation Glycosidases Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Waters Corporation Glycosidases Product Portfolio
- 4.2.5 Waters Corporation Recent Developments
- 4.3 Vaupell Holdings
- 4.3.1 Vaupell Holdings Company Information
- 4.3.2 Vaupell Holdings Business Overview
- 4.3.3 Vaupell Holdings Glycosidases Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Vaupell Holdings Glycosidases Product Portfolio
- 4.3.5 Vaupell Holdings Recent Developments
- 4.4 Takara Bio
- 4.4.1 Takara Bio Company Information
- 4.4.2 Takara Bio Business Overview
- 4.4.3 Takara Bio Glycosidases Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Takara Bio Glycosidases Product Portfolio
- 4.4.5 Takara Bio Recent Developments
- 4.5 Sumitomo Bakelite
- 4.5.1 Sumitomo Bakelite Company Information
- 4.5.2 Sumitomo Bakelite Business Overview
- 4.5.3 Sumitomo Bakelite Glycosidases Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sumitomo Bakelite Glycosidases Product Portfolio
- 4.5.5 Sumitomo Bakelite Recent Developments
- 4.6 Shimadzu Analytical
- 4.6.1 Shimadzu Analytical Company Information
- 4.6.2 Shimadzu Analytical Business Overview
- 4.6.3 Shimadzu Analytical Glycosidases Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Shimadzu Analytical Glycosidases Product Portfolio
- 4.6.5 Shimadzu Analytical Recent Developments
- 4.7 S-BIO
- 4.7.1 S-BIO Company Information
- 4.7.2 S-BIO Business Overview
- 4.7.3 S-BIO Glycosidases Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 S-BIO Glycosidases Product Portfolio
- 4.7.5 S-BIO Recent Developments
- 4.8 RayBiotech
- 4.8.1 RayBiotech Company Information
- 4.8.2 RayBiotech Business Overview
- 4.8.3 RayBiotech Glycosidases Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 RayBiotech Glycosidases Product Portfolio
- 4.8.5 RayBiotech Recent Developments
- 4.9 RandD Systems
- 4.9.1 RandD Systems Company Information
- 4.9.2 RandD Systems Business Overview
- 4.9.3 RandD Systems Glycosidases Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 RandD Systems Glycosidases Product Portfolio
- 4.9.5 RandD Systems Recent Developments
- 4.10 PerkinElmer
- 4.10.1 PerkinElmer Company Information
- 4.10.2 PerkinElmer Business Overview
- 4.10.3 PerkinElmer Glycosidases Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 PerkinElmer Glycosidases Product Portfolio
- 4.10.5 PerkinElmer Recent Developments
- 4.11 New England Biolabs
- 4.11.1 New England Biolabs Company Information
- 4.11.2 New England Biolabs Business Overview
- 4.11.3 New England Biolabs Glycosidases Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 New England Biolabs Glycosidases Product Portfolio
- 4.11.5 New England Biolabs Recent Developments
- 4.12 Merck Group
- 4.12.1 Merck Group Company Information
- 4.12.2 Merck Group Business Overview
- 4.12.3 Merck Group Glycosidases Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Merck Group Glycosidases Product Portfolio
- 4.12.5 Merck Group Recent Developments
- 4.13 Geno Technology
- 4.13.1 Geno Technology Company Information
- 4.13.2 Geno Technology Business Overview
- 4.13.3 Geno Technology Glycosidases Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Geno Technology Glycosidases Product Portfolio
- 4.13.5 Geno Technology Recent Developments
- 4.14 FUJIFILM Wako Pure Chemical Corporation
- 4.14.1 FUJIFILM Wako Pure Chemical Corporation Company Information
- 4.14.2 FUJIFILM Wako Pure Chemical Corporation Business Overview
- 4.14.3 FUJIFILM Wako Pure Chemical Corporation Glycosidases Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 FUJIFILM Wako Pure Chemical Corporation Glycosidases Product Portfolio
- 4.14.5 FUJIFILM Wako Pure Chemical Corporation Recent Developments
- 4.15 Danaher
- 4.15.1 Danaher Company Information
- 4.15.2 Danaher Business Overview
- 4.15.3 Danaher Glycosidases Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Danaher Glycosidases Product Portfolio
- 4.15.5 Danaher Recent Developments
- 4.16 Cambridge Isotope Laboratories
- 4.16.1 Cambridge Isotope Laboratories Company Information
- 4.16.2 Cambridge Isotope Laboratories Business Overview
- 4.16.3 Cambridge Isotope Laboratories Glycosidases Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Cambridge Isotope Laboratories Glycosidases Product Portfolio
- 4.16.5 Cambridge Isotope Laboratories Recent Developments
- 4.17 Bruker
- 4.17.1 Bruker Company Information
- 4.17.2 Bruker Business Overview
- 4.17.3 Bruker Glycosidases Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Bruker Glycosidases Product Portfolio
- 4.17.5 Bruker Recent Developments
- 4.18 Agilent Technologies
- 4.18.1 Agilent Technologies Company Information
- 4.18.2 Agilent Technologies Business Overview
- 4.18.3 Agilent Technologies Glycosidases Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Agilent Technologies Glycosidases Product Portfolio
- 4.18.5 Agilent Technologies Recent Developments
5 Global Glycosidases Market Scenario by Region
- 5.1 Global Glycosidases Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Glycosidases Sales by Region: 2021-2032
- 5.2.1 Global Glycosidases Sales by Region: 2021-2026
- 5.2.2 Global Glycosidases Sales by Region: 2027-2032
- 5.3 Global Glycosidases Revenue by Region: 2021-2032
- 5.3.1 Global Glycosidases Revenue by Region: 2021-2026
- 5.3.2 Global Glycosidases Revenue by Region: 2027-2032
- 5.4 North America Glycosidases Market Facts & Figures by Country
- 5.4.1 North America Glycosidases Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Glycosidases Sales by Country (2021-2032)
- 5.4.3 North America Glycosidases Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Glycosidases Market Facts & Figures by Country
- 5.5.1 Europe Glycosidases Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Glycosidases Sales by Country (2021-2032)
- 5.5.3 Europe Glycosidases Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Glycosidases Market Facts & Figures by Country
- 5.6.1 Asia Pacific Glycosidases Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Glycosidases Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Glycosidases Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Glycosidases Market Facts & Figures by Country
- 5.7.1 South America Glycosidases Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Glycosidases Sales by Country (2021-2032)
- 5.7.3 South America Glycosidases Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Glycosidases Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Glycosidases Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Glycosidases Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Glycosidases Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Glycosidases Sales by Type (2021-2032)
- 6.1.1 Global Glycosidases Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Glycosidases Sales Market Share by Type (2021-2032)
- 6.2 Global Glycosidases Revenue by Type (2021-2032)
- 6.2.1 Global Glycosidases Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Glycosidases Revenue Market Share by Type (2021-2032)
- 6.3 Global Glycosidases Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Glycosidases Sales by Application (2021-2032)
- 7.1.1 Global Glycosidases Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Glycosidases Sales Market Share by Application (2021-2032)
- 7.2 Global Glycosidases Revenue by Application (2021-2032)
- 7.2.1 Global Glycosidases Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Glycosidases Revenue Market Share by Application (2021-2032)
- 7.3 Global Glycosidases Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Glycosidases Value Chain Analysis
- 8.1.1 Glycosidases Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Glycosidases Production Mode & Process
- 8.2 Glycosidases Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Glycosidases Distributors
- 8.2.3 Glycosidases Customers
9 Global Glycosidases Analyzing Market Dynamics
- 9.1 Glycosidases Industry Trends
- 9.2 Glycosidases Industry Drivers
- 9.3 Glycosidases Industry Opportunities and Challenges
- 9.4 Glycosidases Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst